Hypertriglyceridemia, higher levels of LDL cholesterol, lipoprotein(a) particles, and apolipoprotein B (Apo B)-containing lipoproteins as well as low high-density lipoprotein (HDL) levels are most frequent alterations observed in CKD patients. This evidence concerns the gene APOB and chronic kidney disease.